National Cancer Institute
National Cancer Institute
Vilnius, Lithuania1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors | Solid Tumors, Adult | Active, not recruiting | Phase 1 | 2025-06-26 | NCT05354323 |